Premium
Pelvic exenteration
Author(s) -
Lindsey William F.,
Wood Donald K.,
Briele Henry A.,
Greager John A.,
Walker Michael J.,
Bork Jeffrey,
Gupta Tapas K. Das
Publication year - 1985
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.2930300409
Subject(s) - medicine , pelvic exenteration , surgery
Sixty‐eight patients at the University of Illinois, Cook County, and the West Side Veterans Administration hospitals underwent pelvic exenteration for advanced pelvic malignancies during the 15‐year period from 1969 to 1984. Thirty‐two had colorectal cancers, eleven cervical, seven bladder, and six vulvar; in twelve the cancers were in miscellaneous pelvic sites. Forty‐five exenterations were done with intent to cure, and twenty‐three for palliation of patients with bulky, necrotic tumors that had caused symptomatic fistulae, local sepsis, chronic bleeding, or severe localized pain. The total 30‐day postoperative mortality was 4.4% (3/68). The 5‐year survival rate of patients who underwent curative exenteration was 33% (median 27 months). Pelvic exenteration appears to be a feasible surgical procedure for a variety of advanced malignancies as well as for palliation of severely symptomatic patients.